These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1828833

  • 1. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha.
    Bellnier DA.
    J Photochem Photobiol B; 1991 Jan; 8(2):203-10. PubMed ID: 1828833
    [Abstract] [Full Text] [Related]

  • 2. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 4. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
    Waldow SM, Henderson BW, Dougherty TJ.
    Lasers Surg Med; 1987 Aug 01; 7(1):12-22. PubMed ID: 2952850
    [Abstract] [Full Text] [Related]

  • 5. Effect of photodynamic therapy on blood flow in normal and tumor vessels.
    Wieman TJ, Mang TS, Fingar VH, Hill TG, Reed MW, Corey TS, Nguyen VQ, Render ER.
    Surgery; 1988 Sep 01; 104(3):512-7. PubMed ID: 2970687
    [Abstract] [Full Text] [Related]

  • 6. Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.
    Bellnier DA, Dougherty TJ.
    J Photochem Photobiol B; 1989 Nov 01; 4(2):219-25. PubMed ID: 2556509
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of photodynamic therapy by heat: effect of sequence and time interval between treatments in vivo.
    Waldow SM, Henderson BW, Dougherty TJ.
    Lasers Surg Med; 1985 Nov 01; 5(2):83-94. PubMed ID: 3157847
    [Abstract] [Full Text] [Related]

  • 8. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy.
    Ferrario A, Gomer CJ.
    Cancer Res; 1990 Feb 01; 50(3):539-43. PubMed ID: 2137023
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy for human malignant mesothelioma in the nude mouse.
    Feins RH, Hilf R, Ross H, Gibson SL.
    J Surg Res; 1990 Oct 01; 49(4):311-4. PubMed ID: 2145473
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.
    Gołab J, Wilczyński G, Zagozdzon R, Stokłosa T, Dabrowska A, Rybczyńska J, Wasik M, Machaj E, Ołda T, Kozar K, Kamiński R, Giermasz A, Czajka A, Lasek W, Feleszko W, Jakóbisiak M.
    Br J Cancer; 2000 Apr 01; 82(8):1485-91. PubMed ID: 10780531
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.
    Gilson D, Ash D, Driver I, Feather JW, Brown S.
    Br J Cancer; 1988 Nov 01; 58(5):665-7. PubMed ID: 2975499
    [Abstract] [Full Text] [Related]

  • 12. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS, Brasseur N, La Madeleine C, van Lier JE.
    Anticancer Res; 1996 Nov 01; 16(4A):1887-92. PubMed ID: 8712717
    [Abstract] [Full Text] [Related]

  • 13. A test of different photosensitizers for photodynamic treatment of cancer in a murine tumor model.
    Evensen JF, Moan J.
    Photochem Photobiol; 1987 Nov 01; 46(5):859-65. PubMed ID: 2964667
    [No Abstract] [Full Text] [Related]

  • 14. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
    Henderson BW, Fingar VH.
    Photochem Photobiol; 1989 Mar 01; 49(3):299-304. PubMed ID: 2525260
    [Abstract] [Full Text] [Related]

  • 15. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response.
    Fingar VH, Henderson BW.
    Photochem Photobiol; 1987 Nov 01; 46(5):837-41. PubMed ID: 2964665
    [No Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy of murine skin tumors using Photofrin-II.
    Mukhtar H, Agarwal R, Athar M, Lewen RL, Elmets CA, Bickers DR.
    Photodermatol Photoimmunol Photomed; 1991 Aug 01; 8(4):169-75. PubMed ID: 1839955
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system.
    Hammer-Wilson MJ, Ghahramanlou M, Berns MW.
    Lasers Surg Med; 1999 Aug 01; 24(4):276-84. PubMed ID: 10327046
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells.
    Ma LW, Moan J, Berg K, Peng Q, Steen HB.
    Radiat Res; 1993 Apr 01; 134(1):22-8. PubMed ID: 8475251
    [Abstract] [Full Text] [Related]

  • 19. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 01; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 20. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
    Igarashi A, Konno H, Tanaka T, Nakamura S, Sadzuka Y, Hirano T, Fujise Y.
    Toxicol Lett; 2003 Nov 30; 145(2):133-41. PubMed ID: 14581165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.